Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial.
Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. Maitre P, et al. Among authors: phurailatpam r. Int J Radiat Oncol Biol Phys. 2024 Mar 28:S0360-3016(24)00439-5. doi: 10.1016/j.ijrobp.2024.03.023. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38552989
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial.
Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U. Murthy V, et al. Among authors: phurailatpam r. J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26. J Clin Oncol. 2021. PMID: 33497252 Clinical Trial.
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D'Cruz A. Gupta T, et al. Among authors: phurailatpam r. Radiother Oncol. 2012 Sep;104(3):343-8. doi: 10.1016/j.radonc.2012.07.001. Epub 2012 Jul 30. Radiother Oncol. 2012. PMID: 22853852 Clinical Trial.
Development and Validation of Single-Optimization Knowledge-Based Volumetric Modulated Arc Therapy Model Plan in Nasopharyngeal Carcinomas.
Sinha S, Kumar A, Maheshwari G, Mohanty S, Joshi K, Shinde P, Gupta D, Kale S, Phurailatpam R, Swain M, Budrukkar A, Kinhikar R, Ghosh-Laskar S. Sinha S, et al. Among authors: phurailatpam r. Adv Radiat Oncol. 2023 Jul 9;9(1):101311. doi: 10.1016/j.adro.2023.101311. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260222 Free PMC article.
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial.
Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, Maheshwari A, Shylasree TS, Ghosh J, Paul SN, Phurailatpam R, Charnalia M, Alone M, Swamidas J, Mahantshetty U, Deodhar K, Kerkar R, Shrivastava SK. Chopra S, et al. Among authors: phurailatpam r. J Clin Oncol. 2021 Nov 20;39(33):3682-3692. doi: 10.1200/JCO.20.02530. Epub 2021 Sep 10. J Clin Oncol. 2021. PMID: 34506246 Clinical Trial.
Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study.
Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, Mahantshetty U, Phurailatpam R, Paul SN, Shrivastava SK. Chopra S, et al. Among authors: phurailatpam r. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):630-5. doi: 10.1016/j.ijrobp.2013.11.214. Int J Radiat Oncol Biol Phys. 2014. PMID: 24521678
Radiation necrosis of the bone, cartilage or cervical soft-tissues following definitive high-precision radio(chemo)therapy for head-neck cancer: uncommon and under-reported phenomenon.
Gupta T, Maheshwari G, Gudi S, Chatterjee A, Phurailatpam R, Prabhash K, Budrukkar A, Ghosh-Laskar S, Agarwal JP. Gupta T, et al. Among authors: phurailatpam r. J Laryngol Otol. 2021 Nov 26:1-22. doi: 10.1017/S0022215121003790. Online ahead of print. J Laryngol Otol. 2021. PMID: 34823635 No abstract available.
43 results